Drugs / Hidra1
last change Mar 2016 re-read 3 minutes ago

Hidra1

Developed for
postmenopausal atrophic vaginitis
Investigated by
Farmoquimica S.A.

Trials 1

201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02571127 Oct 2015 → Feb 2016 postmenopausal atrophic vaginitis Farmoquimica S.A. Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Hidra1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02571127 ↗
Route Other “Non-hormonal Intravaginal Gel” NCT02571127 ↗